Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Brain Ischemia D002545 89 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Hyperlipidemias D006949 73 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia P388 D007941 43 associated lipids
Occupational Diseases D009784 42 associated lipids
Hypotension D007022 41 associated lipids
Adenoma D000236 40 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Heart Failure D006333 36 associated lipids
Epilepsy D004827 35 associated lipids
Hyperplasia D006965 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Alcoholism D000437 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Anemia D000740 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Hepatitis D006505 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Dehydration D003681 11 associated lipids
Iron Overload D019190 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Myocardial Stunning D017682 10 associated lipids
Hearing Disorders D006311 10 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Leprosy D007918 8 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Jaundice, Neonatal D007567 7 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Thrombophlebitis D013924 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Testicular Neoplasms D013736 5 associated lipids
Glucosephosphate Dehydrogenase Deficiency D005955 5 associated lipids
Osteomalacia D010018 5 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Carcinogenesis D063646 3 associated lipids
Biliary Tract Diseases D001660 3 associated lipids
Addison Disease D000224 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Anemia, Refractory D000753 3 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Gilbert Disease D005878 2 associated lipids
Fasciitis D005208 2 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Neurocysticercosis D020019 1 associated lipids
Telangiectasia, Hereditary Hemorrhagic D013683 1 associated lipids
Hemosiderosis D006486 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
pmid:26686338
pmid:26657161
pmid:24725852
pmid:24611780
pmid:16504354
pmid:16286429
pmid:21479479
pmid:18571185
pmid:29168243
pmid:29027212
pmid:
pmid:6209078
pmid:9278881
Dai P et al. Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. 2015 AAPS J pmid:25762448
Gombotz H et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. 2000 Acta Anaesthesiol Scand pmid:10903019
Peduto VA et al. Stimulation of drug-metabolizing enzymes by nitrous oxide in the rat. 1983 Acta Anaesthesiol Scand pmid:6141696
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-yttriate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836844
Lv YK et al. Poly[dimethyl-ammonium [aquadi-μ(2)-oxalato-samarate(III)] trihydrate]. 2011 Acta Crystallogr Sect E Struct Rep Online pmid:21836843
Kim YH et al. Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. 2009 Acta Haematol. pmid:19332985
Nonaka D et al. Gelatinous bone marrow transformation complicated by self-induced malnutrition. 1998 Acta Haematol. pmid:9792939
Kawasaki H et al. Effect of corticosteroid treatment on bilirubin metabolism in chronic aggressive hepatitis. 1977 Acta Hepatogastroenterol (Stuttg) pmid:883466
Budillon G et al. Urinary excretion of D-glucaric acid, total glucuronic acid and total porphyrins in porphyria cutanea tarda. 1978 Acta Hepatogastroenterol (Stuttg) pmid:696201
Horváth T et al. Drug metabolism in alcoholic liver disease. 1982 Acta Med Acad Sci Hung pmid:7185242
Várkonyi A et al. Non-specific drug-metabolizing enzyme activity in Gilbert disease. 1984 Acta Med Hung pmid:6440117
Horváth T et al. Disorders of biotransformation during the progression of alcoholic liver disease. 1986 Acta Med Hung pmid:3601579
Horváth T et al. Correlation between biochemical tests, parameters of drug elimination and hepatic enzyme induction in chronic liver diseases. 1983 Acta Med Hung pmid:6674914
Krafft A et al. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. 2000 Acta Obstet Gynecol Scand pmid:10949245
Cassimos C et al. Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. 1977 Acta Paediatr Scand pmid:868519
Talafant E et al. Serum gamma-glutamyl transpeptidase activity and urinary D-glucaric acid excretion in newborns in the first week of life. Effects of phenobarbital and nicethamide combination. 1976 Acta Paediatr Scand pmid:11634
Anbu AT et al. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. 2005 Acta Paediatr. pmid:16431410
Marselos M Genetic variation of drug-metabolizing enzymes in the wistar rat. 1976 Acta Pharmacol Toxicol (Copenh) pmid:821309
Pár A et al. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease. 1984 Acta Physiol Hung pmid:6152369
Horváth T et al. Drug metabolism in drug-induced liver diseases: pathogenetic role of active metabolites. 1989 Acta Physiol Hung pmid:2596319
Del Ninno E et al. [The d-glucaric acid test in the evaluation of the inductive properties of phenobarbital and spironalactone]. 1974 Acta Vitaminol. Enzymol. pmid:4480343
Bolaños L et al. Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. 2008 Adv Perit Dial pmid:18986009
Roots I et al. Comparison of methods to study enzyme induction in man. 1975 Adv. Exp. Med. Biol. pmid:239546
Calcium-D-glucarate. 2002 Altern Med Rev pmid:12197785
Lord RS and Bralley JA Clinical applications of urinary organic acids. Part I: Detoxification markers. 2008 Altern Med Rev pmid:18950247
Weiersmüller A et al. The influence of prednisolone on hepatic function in normal subjects. Effects on galactose elimination capacity, sulfobromophthalein transport maximum and storage capacity, and D-glucaric acid output. 1977 Am J Dig Dis pmid:857663
Carrella M et al. An evaluation of urinary D-glucaric acid excretion during acute hepatitis in man. 1978 Am J Dig Dis pmid:619622
Nguyen TV Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients. 2009 Am J Health Syst Pharm pmid:19498125
Wall GC and Pauly RA Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. 2008 Am J Health Syst Pharm pmid:18192261
Thomas J and Martinez A Blood conservation in the critically ill. 2007 Am J Health Syst Pharm pmid:17687066
Newman MA et al. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses. 1994 Am J Public Health pmid:8179062
Buchanan N et al. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor. 1979 Am. J. Clin. Nutr. pmid:506967
Kulnigg S et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. 2009 Am. J. Gastroenterol. pmid:19491860
Gasche C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Am. J. Gastroenterol. pmid:11513178
Schröder O et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. 2005 Am. J. Gastroenterol. pmid:16279906
Derman R et al. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. 2017 Am. J. Hematol. pmid:28052413
Hetzel D et al. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. 2014 Am. J. Hematol. pmid:24639149